Product

Triple combination formula

1 clinical trial

1 indication

Indication
Melasma
Clinical trial
Oral Isotretinoin in The Treatment of Melasma A Randomized Controlled Clinical Trial
Status: Recruiting, Estimated PCD: 2024-01-31